MH Karol, DJ Tollerud, TP Campbell, L Fabbri, P Maestrelli, M Saetta and CE Mapp
Department of Environmental and Occupational Health, Graduate School of Public Health, University of Pittsburgh, Pennsylvania.

Development of asthma after exposure to toluene diisocyanate (TDI) has been recognized in a variety of occupational settings. However, the pathogenesis of isocyanate-induced asthma remains controversial. In particular, the role of IgE in the development of TDI-induced asthma has remained uncertain. To investigate predictive factors for response to inhalation challenge with TDI, we analyzed data from 63 subjects referred for evaluation of respiratory symptoms thought to be related to TDI sensitization. All subjects underwent interview, routine phlebotomy, spirometry, methacholine challenge, and allergy skin testing prior to TDI challenge. Spirometry and methacholine challenge were repeated 1 day after TDI challenge. The cumulative dose of methacholine needed to produce a 20% decrease in FEV1 (PD20) was determined. A PD20 of 1.4 mg or more was considered normal. Subjects were challenged by exposure to 5 to 10 ppb TDI for up to 30 min in a 9 m3 exposure chamber. A positive response was a 20% or more decrease in FEV1 within 1 h (early) or beyond 1 h (late) after TDI exposure. Thirty- four subjects (54%) had a positive response, of whom 12 (35% of responders) had isolated early responses, 13 (38%) had isolated late responses, and the remainder had dual responses. Thirty-two individuals (51%) had a positive response to methacholine (AR+) prior to TDI challenge. AR+ was strongly associated with a positive TDI challenge: 23 AR+ subjects (72%) had a positive TDI challenge, compared with only 11 AR- subjects (35%) (p < 0.01). AR positivity did not predict the time of onset of TDI response.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				J. Pauluhn Brown Norway Rat Asthma Model of Diphenylmethane-4,4'-Diisocyanate (MDI): Analysis of the Elicitation Dose-Response Relationship Toxicol. Sci., August 1, 2008; 104(2): 320 - 331. [Abstract] [Full Text] [PDF]

				C. E. Mapp, P. Boschetto, P. Maestrelli, and L. M. Fabbri Occupational Asthma Am. J. Respir. Crit. Care Med., August 1, 2005; 172(3): 280 - 305. [Abstract] [Full Text] [PDF]

				J. Sastre, O. Vandenplas, and H-S. Park Pathogenesis of occupational asthma Eur. Respir. J., August 1, 2003; 22(2): 364 - 373. [Abstract] [Full Text] [PDF]

				H. G. Ortega, D. N. Weissman, D. L. Carter, and D. Banks Use of Specific Inhalation Challenge in the Evaluation of Workers at Risk for Occupational Asthma* : A Survey of Pulmonary, Allergy, and Occupational Medicine Residency Training Programs in the United States and Canada Chest, April 1, 2002; 121(4): 1323 - 1328. [Abstract] [Full Text] [PDF]

				A. V. WISNEWSKI, R. SRIVASTAVA, C. HERICK, L. XU, R. LEMUS, H. CAIN, N. M. MAGOSKI, M. H. KAROL, K. BOTTOMLY, and C. A. REDLICH Identification of Human Lung and Skin Proteins Conjugated with Hexamethylene Diisocyanate In Vitro and In Vivo Am. J. Respir. Crit. Care Med., December 1, 2000; 162(6): 2330 - 2336. [Abstract] [Full Text]

				H. SCHEERENS, T. L. BUCKLEY, T. L. MUIS, J. GARSSEN, J. DORMANS, F. P. NIJKAMP, and H. VAN LOVEREN Long-term Topical Exposure to Toluene Diisocyanate in Mice Leads to Antibody Production and In Vivo Airway Hyperresponsiveness Three Hours after Intranasal Challenge Am. J. Respir. Crit. Care Med., April 1, 1999; 159(4): 1074 - 1080. [Abstract] [Full Text] [PDF]